Deloitte Honorees

WILTON: Deloitte released its 2016 Technology Fast 500 rankings of the fastest-growing tech companies in North America.

Seven Connecticut companies have made the list, including: New Haven’s Achillion Pharmaceuticals. The  biotechnology/pharmaceutical company came in at no. 43, with 2,436 percent (revenue growth between 2012 and 2015). Achillion’s growth was driven by a joint marketing and development agreement with Johnson and Johnson’s Jannsen Pharmaceuticals, for rights to Achillion’s Hepatitus C drugs. The deal brought more than $225 million to the company and potential payments of $1 billion if regulatory and sales goals are met.

Farmington’s Evariant software markets a healthcare Customer Relationships Marketing [CRM] platform that according to the company “combines digital marketing solutions, big data, and analytics to grow patient engagement.” Deloitte placed Evariant at number 239 on their national list with a growth rate of 303%.

HPOne, [previously Healthplan One] of Trumbull, came in at 357 in the index with a 199% growth rate. It is the fifth year in a row that the company made the list. HPOne provides services to health plans that range from staffing to digital marketing, sales service and care management programs.

At 385 on the index Madison’s Clarity Software was recognized for its 176% growth rate. Clarity also services, health insurance plans, helping them manage their documents across print, mobile, email and web. In October Fallon Health Plans of Worcester, MA,  expanded their relationship with the company by having Clarity manage the company “explanation of benefits” documents.

Norwalk’s Etouches helps companies manages their events and it has made them one of the fastest growing companies in Connecticut and the US, it hit the list at 461 with a 132% growth rate.

Number 469 on Deloitte’s Technology Fast 500 was Core Informatics, a Branford software, company that provides “laboratory data management solutions to leading biopharma, genomics, and other scientific organizations” and created a 130 percent growth rate.

New Haven’s recently embattled super company, Alexion Pharmaceuticals, is still growing but it going through a difficult patch with the” resignation” of its CEO and CFO, an internal investigation over its sales practices, a horde of class action lawsuits in the hopper and a recently failed clinical trial. Nevertheless analysts are still positive on the stock and new products will nearly double sales in the next few years. With $2.5 billion in sales it is the largest Connecticut company on the list and its 130% placed it at 473.